Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [654]
News [1409]
Articles [231]
Editorials [9]
Conferences [81]
elearning [12]
The value of surgery in ovarian cancer
Prof Christina Fotopoulou - Queen Charlotte's and Chelsea Hospital, London, UK
The value of surgery in ovarian cancer ( Prof Christina Fotopoulou - Queen Charlotte's and Chelsea Hospital, London, UK )
24 May 2019
Latest in ovarian cancer treatment
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Latest in ovarian cancer treatment ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
24 May 2019
Bladder Problems following ovarian cancer treatment
Ellie Stewart - Guy’s and St Thomas NHS Foundation Trust, London, UK
Bladder Problems following ovarian cancer treatment ( Ellie Stewart - Guy’s and St Thomas NHS Foundation Trust, London, UK )
24 May 2019
Treating ovarian cancer patients with PARP inhibitors
Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA
Treating ovarian cancer patients with PARP inhibitors ( Kimberly Halla - Arizona Oncology Associates PC, Scottsdale, USA )
8 May 2019
PARP inhibitors and their side effects in solid tumour therapy
Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA
PARP inhibitors and their side effects in solid tumour therapy ( Paula Anastasia - David Geffen School of Medicine at UCLA Los Angeles, USA )
8 May 2019
Providing safe care to hereditary cancer patients and families
Suzanne Mahon - Saint Louis University, Missouri, USA
Providing safe care to hereditary cancer patients and families ( Suzanne Mahon - Saint Louis University, Missouri, USA )
8 May 2019
Treating ovarian cancers with PARP inhibitors
Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA
Treating ovarian cancers with PARP inhibitors ( Lisa Marie Juden - Dana-Farber Cancer Institute, Boston, MA )
8 May 2019
Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1...
Dr James Gulley - National Cancer Institute, Bethesda, USA
Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies ( Dr James Gulley - National Cancer Institute, Bethesda, USA )
15 Apr 2019
Using T cell engineering plus triple checkpoint blockade to enhance the...
Dr Kristin Anderson - Fred Hutchinson Cancer Research Center, Seattle, USA
Using T cell engineering plus triple checkpoint blockade to enhance the efficacy of adoptive immunotherapy in ovarian cancer ( Dr Kristin Anderson - Fred Hutchinson Cancer Research Center, Seattle, USA )
15 Apr 2019
Combining the SLP vaccine with chemo-immunotherapy in order to increase the HPV...
Prof Kees Melief - Leiden University Medical Center, Leiden, Netherlands
Combining the SLP vaccine with chemo-immunotherapy in order to increase the HPV-specific T-cell response in cervical cancer ( Prof Kees Melief - Leiden University Medical Center, Leiden, Netherlands )
15 Apr 2019
Gynaecological cancer: Where are we now?
Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands
Gynaecological cancer: Where are we now? ( Dr Nelleke Ottevanger - Radboud University Medical Center, Nijmegen, Netherlands )
21 Mar 2019
Innovating India: Rural healthcare in Salboni
Innovating India: Rural healthcare in Salboni ( )
28 Feb 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation